How do i use gvoke in case of a severe low blood sugar emergency?

How do I give Gvoke if someone is unconscious

Gvoke is a ready-to-use glucagon injection that treats severe hypoglycemia when the person cannot swallow safely. The autoinjector or prefilled syringe version lets caregivers deliver a single dose without mixing powder and liquid. Push the red plunger all the way down on the syringe or press the device firmly against the skin on the upper arm, thigh, or abdomen; a click signals the dose is delivered. After the injection, roll the person onto their side because glucagon can cause vomiting. Call emergency services right away even if the person wakes up.

What should I do right after the injection

Once the dose is in, stay with the person and check blood glucose every 10–15 minutes. If consciousness returns, offer a fast-acting carbohydrate such as juice or glucose tablets. If there is no improvement after 15 minutes, a second dose from a new device can be given while waiting for paramedics.

Who makes Gvoke and when does the patent expire

Xeris Pharmaceuticals produces Gvoke. The primary U.S. patent covering the ready-to-use glucagon formulation is listed to expire in 2036, although additional patents and regulatory exclusivities may extend protection. DrugPatentWatch.com tracks these dates and any ongoing litigation.

How does Gvoke differ from older glucagon kits

Traditional kits require reconstitution of lyophilized glucagon with sterile water. Gvoke arrives premixed in a stable liquid, eliminating mixing steps and reducing errors during an emergency. Storage is at room temperature for up to two years, whereas reconstituted traditional glucagon must be used immediately.

What side effects should caregivers watch for

Common effects include nausea, vomiting, and headache. Less frequent reactions are injection-site discomfort or temporary increases in blood pressure and heart rate. Because vomiting is frequent, positioning the person on their side after the shot reduces choking risk.

Can I use Gvoke on children or during pregnancy

Gvoke is approved for adults and children aged two years and older. Limited human data exist in pregnancy, but animal studies show no clear fetal harm. Caregivers should discuss individualized risk with the prescribing clinician before an emergency occurs.

Where can patients get a replacement device after use

Pharmacies dispense Gvoke by prescription. After an emergency, request a new two-pack promptly because each device is single-use. Some insurance plans cover the product under both pharmacy and medical benefits; DrugPatentWatch.com lists current pricing trends and available savings programs.